Thursday, August 11, 2011

Jennerex raises $8.6M in private placement

Cancer drug company Jennerex Inc. raised $8.6 million in gross proceeds from a private placement.
The San Francisco company didn’t say what it is likely to net after expenses.
Jennerex, led by CEO and President David Kim, M.D., is testing a treatment for liver cancer which is in mid-stage clinical development. It plans a Phase IIb test of that treatment “in the coming months.”

No comments:

Post a Comment